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Abstract
Sellar masses are frequently adenomatous pituitary tumors. Metastatic disease is unusual, often mimicking the presentations
of adenomas. Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy but unusual to have a pituitary
metastasis (PM). A 65-year-old man presented with headache, diplopia, ptosis, decreased vision in the right eye and unintentional
weight loss of 32lbs. Preliminary out-patient work-up revealed a mass in the pituitary region. Cranial imaging showed 3.1 cm ×
3.2 cm × 4.4 cm lesion. Abdominal imaging (computed tomography and magnetic resonance imaging) demonstrated a lobulated,
nodular and heterogeneous right lobe of the liver. Trans-sphenoidal resection of the sellar mass favored metastatic HCC on
histology. Liver biopsy confirmed HCC. We recommend maintaining an increased clinical suspicion upon evaluation of nonclassical
clinical and radiological presentations of suspected PM/malignancy; as well as pursuing additional investigations in all early cases.
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INTRODUCTION
Sellar masses are most frequently primary pituitary tumors
of the adenomatous type. Metastatic malignancies are
471

an unusual clinical presentation.[1] However, metastatic
disease (including isolated pituitary metastasis [PM]) may
mimic the clinical, endocrinological and radio graphical
presentations of primary pituitary adenomas (PA)[2] which
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are much more common. Differentiating between these
lesions may be difficult. Hence, any unusual presentation
or clinical course of a PA must raise suspicion for the
possibility of PM and scull base metastasis with an
undiagnosed primary tumor.[3,4]
Almost all types of malignancies can be detected in sellar
masses, though most derive from primaries in the breast
and lung cancer. PM account for about 1% of operative
pituitary lesions. The prognosis of patients with PM is
poor, with a mean survival of 6-7 months, due to the
aggressiveness of the primary neoplasm. Of note, most
pituitary metastases appear to be asymptomatic and
therefore, metastatic involvement of the pituitary gland
is most frequently found on autopsy specimens versus
recognized clinically. In symptomatic/operative cases,
metastases are initially suspected during surgery because
of the atypical appearance of the tumor and confirmation
of the diagnosis relies on the histological study.[5,6]
The clinical presentation of the sellar mass may help
the differential diagnosis because visual field defects and
anterior pituitary dysfunction are mostly found in pituitary
macroadenomas. Although symptomatic metastases
commonly present with diabetes insipidus, headache,
hypopituitary syndromes, visual fields and extraocular
palsies have also been reported. The clinical features of
metastases correlate well with published reports showing
that tumor metastases are more often found in the posterior
lobe than in the anterior lobe, due to the different blood
supplies.[2-6]

CASE REPORT
A 65-year-old Hispanic male with a pertinent medical
history of hypertension, obesity, dyslipidemia, and diabetes
mellitus who presented with progressive frontal and
biparietal headache. The headache was associated with
photophobia, diplopia, decreased visual acuity and ptosis of
the right eye as well as, nausea and vomiting for 1-month.
In addition, he reported an unintentional weight loss of 32
pounds over a 2-month period. On physical examination,
he was found to have internuclear opthalmoplegia and
pupil-sparing right third nerve palsy. He was unable to
abduct his left eye past the midline laterally and had
difficulty with upward as well as downward gaze, suggesting
a sixth cranial nerve palsy. No additional cranial nerve
deficits were present. He denied any personal or family
history of malignancy or liver disease. He admitted to a
20-pack year history of smoking and alcohol use.
Prior to presenting at our facility for worsening of
symptoms, the patient underwent an magnetic resonance

imaging (MRI) of the brain [Figures 1, 2a and b], which
showed a mass in the pituitary region involving the sella
as well as the clivus. Further diagnostic work-up, showed
no abnormality in prolactin, thyroid-stimulating hormone,
follicle-stimulating hormone, luteinizing hormone, or
adrenocorticotropic hormone. In view of this hormonal
inactivity, the patient’s intracranial mass was unlikely to
be a PA and alternate diagnoses including meningoma,
chordoma, and metastasis were considered. The patient
was placed on decadron to decrease intracranial pressure
and underwent further evaluation for tumor diagnosis. His
work-up included a coagulation profile demonstrating PT
14.0, international normalized ratio 1.1. Liver function
studies reflected an albumin of 3.9, total bilirubin of
1.1, total protein 7.6, alkaline phosphatase 156, aspartate
aminotranferase 113, and alanine aminotransferase 186.
Hepatitis panel was uniformly negative for active hepatitis
A, B and C, but did show evidence of prior exposure to
hepatitis A and B. An extensive autoimmune work-up for
cirrhosis were all within normal limits except antismooth
muscle antibodies was borderline positive. Tumor marker
screening including alpha-fetoprotein, prostate-specific
antigen, CA 19-9, and carcinoembryonic antigen exhibited
no abnormalities.
A repeat MRI revealed the mass measured 3.1 cm ×
3.2 cm × 4.4 cm and originated from the clivus extending
into the pituitary gland and displacing it cephalad, but
with no extension to the optic chiasm. It affected the
infundibulum pushing it leftward, with slight insinuation
at the cavernous sinus. Heterogeneous enhancement with
a central vascular area was seen, and there was effacement
of the undersurface of the sphenoid sinuses, but no
noted hydrocephalus. Subsequent computed tomography

Figure 1: Magnetic resonance imaging pitutary coronal T2-weighted
sequence demonstrating an iso-intense mass of the clivus displacing
the normal pituitary gland cephalad. The mass does not extend to the
level of the optic chiasm but does displace the infundibulum slightly
leftward
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(CT) scan of the chest, abdomen, and pelvis performed
with intravenous contrast, showed a nodular contour
of the right side of the liver with multiple ill-defined
hypodense lesions, which was highly suspicious for a
multifocal hepatocellular carcinoma (HCC). An abdominal
MRI [Figure 3a and b] was performed with contrast,
which showed a lobulated, nodular and heterogeneous
appearance of the entire right lobe of the liver, which
demonstrated abnormal contrast enhancement during
the arterial phase. The left lobe of the liver was relatively
unaffected.
In the light of the patients sellar mass associated with liver
disease, metastatic hepatic etiologies rose to the top of the
differential and HCC in particular, was strongly suspected.
Subsequently, the patient underwent the trans-sphenoidal
resection of the sellar mass using neuronavigation, with
significant tumor debulking. Grossly, the tumor was
consistent with a soft macroadenoma and consisted of
delicate tan-pink and friable tissue. Intraoperative frozen

a

sections [Figures 4, 5a and b] confirmed metastatic HCC.
Subsequently, a liver biopsy of the affected area was
obtained and was consistent with HCC. This confirmed
the suspected clinicopathologic diagnosis of PM from
HCC.

DISCUSSION
Our patient is a 65-year-old Hispanic gentleman who
presented with multiple cranial neuropathies and a newly
diagnosed sellar mass. A sellar mass was initially suspected
due to his constellation of neurologic symptoms. He was
found to have pupil-sparing partial third nerve palsy, most
likely from extension of the mass and compression of
the third nerve along its course into the cavernous sinus.
He also had left sided cranial nerve six palsy. The sixth
nerve travels through the subarachnoid space where it
ascends the clivus and enters the cavernous sinus. Within
the subarachnoid space, the sixth nerve may be stretched
or compressed against the clivus leading to a sixth nerve
palsy. Upon admission to our institution, his CT scan
showed a large lesion involving the sella with an anterior
expansion towards the nasopharynx than would generally
not be expected in a PA. In addition, on the sagittal bony

b

Figure 2: Magnetic resonance imaging pituitary with and without
contrast post (a) and pre-contrast (b) (respectively) sagittal T1-weighed
images without fat suppression showing a large heterogeneous 3.1
cm × 3.2 cm × 4.4 cm enhancing mass expanding the clivus and
displacing the normal pituitary gland. The mass does have some
pituitary extension displacing the normal pituitary gland cephalad, but
is likely separate from the pituitary gland

a

a

Figure 4: Liver biopsy of the affected area showing hepatoid cells
with pseudoglandular pattern consistent with hepatocellular carcinoma
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b

Figure 3: (a) Magnetic resonance imaging of the abdomen Coronal
Single Shot Fast Spin Echo T2-weighted sequences showing a
heterogeneous large bright T2 signal mass occupying most of the
right lobe of the liver, (b) Magnetic resonance imaging of the abdomen
coronal spoiled gradient T1-weighted post contrast image showing large
mass with nodular heterogeneous boarders. The mass is hypointense
relative to liver parenchyma

b

Figure 5: Permanent section of pituitary lesion showing hepatoid
appearance and pseudoglandular pattern (a) and also showing bile
pigment. (b) The morphology of the tumor is similar to patientæs
liver biopsy which favors the diagnosis of metastatic hepatocellular
carcinoma
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reconstructions of the CT scan, there appeared to be
erosion of the clivus, something that is quite uncommon
with PA. Though the patient’s presentation was suggestive
of a sellar mass it’s imaging was not consistent with a
PA, but rather a lesion of the skull base involving the
clivus, sella, sphenoid sinus, and nasopharyngeal space.
Additionally, as our patient had no findings consistent with
panhypopituitarism or other endocrinopathies. This led
to an expansion of the differential diagnosis to primarily
include metastatic lesions.

of nonclassical inpatient imaging led to appropriate
further investigations and elucidated the distant primary
malignancy.

During his work-up he was found to have a large lesion of
the right side of the liver, which was confirmed on biopsy
to be HCC that is the most common primary malignant
hepatic neoplasm. The reported incidence of HCC has
risen in developed countries in recent years, possibly owing
to the introduction of more sensitive diagnostic tools.[7] In
the majority of cases, HCC arises in the background of
cirrhosis/liver disease due to viral hepatitis or alcoholism;
in only 20% of patients there is no serological evidence of
viral hepatitis. Extrahepatic spread of HCC in the central
nervous systemic uncommon. The most common sites of
distant metastases of HCC are lung and bones. Pituitary
metastases from HCC have only rarely been reported in
literature.[1,8,9]
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Our patient’s unique presentation and scarcity of related
published data make this case an unusual diagnostic
challenge. Lack of concomitant presenting complaints
or previous history suspicious for underlying malignancy
combined with a classical presentation of sellar mass likely
led to the initial outpatient diagnostic presumption of PA.
However, increased clinical suspicion upon evaluation
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